MCK - McKesson Corporation

NYSE - Nasdaq Real Time Price. Currency in USD

390.16

+0.93

(+0.24%)

At close: 04:01PM EDT

392.00

+1.84

(+0.47%)

After hours:

07:59PM EDT

Stock chart is not supported by your current browser

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Triple Moving Average Crossover

Performance Outlook

Short Term
2W - 6W
Mid Term
6W - 9M
Long Term
9M+

Previous Close	389.23
Open	386.13
Bid	384.49 x 800
Ask	395.00 x 1300
Day's Range	385.48 - 391.49
52 Week Range	298.69 - 401.78
Volume	745,378
Avg. Volume	1,001,779

Market Cap	52.906B
Beta (5Y Monthly)	0.58
PE Ratio (TTM)	15.53
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	2.16 (0.55%)
Ex-Dividend Date	May 31, 2023
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

60% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MCK

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

News

Investor's Business Daily
Dow Jones Futures Fall, Techs Jump After Debt-Ceiling Deal; Nvidia, Tesla Rise On News
Tech futures umped up after a debt-ceiling deal. Tesla CEO Elon Musk is in China. Nvidia unveiled new AI offerings.
Investor's Business Daily
AI Stocks: Mobileye Leads Three Near Buy Points
With artificial intelligence stocks all the rage after Nvidia's blockbuster earnings, Mobileye is among three AI stocks on this weekend's watch list.
Motley Fool
If You Invested $20,000 in McKesson in 2018, This Is How Much You Would Have Today
McKesson (NYSE: MCK) is one of the largest pharmaceutical distributors in the country. While this isn't the type of investment you might expect 10x returns from, it can provide stability and even reliable dividend income. On the first day of trading in 2018, shares of McKesson closed at $159.
Investor's Business Daily
IBD Stock Of The Day: Why McKesson And Its Rivals Are 'So Hot' Right Now
McKesson is Wednesday's IBD Stock Of The Day. Drug distributors are hot and MCK stock is consolidating following a strong quarterly report.
Insider Monkey
14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and […]
Motley Fool
Worried About a Recession? 2 Safe Stocks to Buy Now
You may know Pfizer (NYSE: PFE) for its blockbuster coronavirus vaccine. Pfizer may face a bit of a near-term slowdown in revenue. In fact, Pfizer says these launches should result in $20 billion in sales in 2030.
Insider Monkey
Billionaire Andreas Halvorsen’s Viking Global Portfolio: Top 15 Stock Picks
In this piece, we will take a look at the top fifteen stock picks of billionaire Andreas Halvorsen’s Viking Global. For more stocks, head on over to Billionaire Andreas Halvorsen’s Viking Global Portfolio: Top 5 Stock Picks. The world of investing is full of uncertainty. After all, there’s no such thing as a free lunch, […]
Motley Fool
Warren Buffett Has Nearly $1 Billion in This Healthcare Stock: Should You Buy It?
This company is the largest player in the medical distribution industry and is featured in Berkshire Hathaway's investment portfolio.
Motley Fool
5 Stocks You Can Confidently Invest $500 in Right Now
You don't have to worry about pinpointing an entry point if the underlying company is truly built to last.
Investor's Business Daily
After 300% Climb, McKesson Stock Earns Bullish Strength Rating
McKesson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 83.
Zacks
McKesson (MCK) Q4 Earnings Beat Estimates, U.S. Sales Strong
McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
Motley Fool
2 Warren Buffett Stocks to Buy Hand Over Fist in May
It has been said many times before, and it will be many times again: Warren Buffett is the greatest investor of all time. Among the many world-class businesses in Berkshire Hathaway's $345.4 billion investment portfolio, here are two that I think dividend growth investors should strongly consider buying this month. It's no secret that Buffett and his business partner Charlie Munger prefer to invest in businesses that are profitable and possess competitive moats.
Motley Fool
McKesson (MCK) Q4 2023 Earnings Call Transcript
At this time, I would like to turn the call over to Nicole Kramer, manager of investor relations. Today, I'm joined by Brian Tyler, our chief executive officer; and Britt Vitalone, our chief financial officer.
Zacks
McKesson (MCK) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
McKesson (MCK) Q4 Earnings and Revenues Surpass Estimates
McKesson (MCK) delivered earnings and revenue surprises of 0.42% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Here's How Inter Parfums (IPAR) is Placed Ahead of Q1 Earnings
Inter Parfums' (IPAR) Q1 earnings are expected to reflect gains from robust top-line growth, strength across brands, expansions and product launches.
Zacks
McKesson (MCK) to Report Q4 Earnings: Is a Beat in Store?
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
Motley Fool
These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020
The COVID-19 public health emergency is slated to end in the U.S. on May 11. Three of the best-performing healthcare stocks since then include Moderna (NASDAQ: MRNA), McKesson (NYSE: MCK), and Eli Lilly (NYSE: LLY). It has multiple products in its approval pipeline, including a vaccine for the respiratory syncytial virus that has been highly effective in late-stage trials.
Zacks
Staar Surgical (STAA) Beats Q1 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 63.64% and 10.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Investopedia
10 Biggest Healthcare Companies
The healthcare sector includes companies that produce medical goods, such as drugs and medical devices, and companies that provide medical services, such as health insurance or hospital administration.
Zacks
McKesson (MCK) Gains As Market Dips: What You Should Know
In the latest trading session, McKesson (MCK) closed at $361, marking a +1.97% move from the previous day.
Zacks
SmileDirectClub (SDC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
SmileDirectClub (SDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Is a Beat Likely for Cardinal Health (CAH) in Q3 Earnings?
Cardinal Health's (CAH) third-quarter fiscal 2023 results are expected to reflect solid performance in the Pharmaceutical segment. However, inflationary pressure is likely to have continued.
Zacks
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.